Axi-cel and liso-cel showed a significant improvement in PFS and a strong trend in OS in two phase III clinical studies in high-risk RR LBCL compared with salvage therapy (ST) followed by autologous stem cell transplantation (ASCT) ( 29 – 32 ).
← all excerpts
Effectiveness of CAR-T treatment toward the potential risk of second malignancies.
1
—
—